Clinical Trial Update: A Study of Mitomycin C, Irinotecan, and Cetuximab [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating mitomycin C, irinotecan, and cetuximab for colorectal cancer was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-07-10